These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15856032)

  • 1. P53 abnormalities and outcomes in colorectal cancer: a systematic review.
    Smith FM; Stephens RB; Kennedy MJ; Reynolds JV
    Br J Cancer; 2005 May; 92(9):1813. PubMed ID: 15856032
    [No Abstract]   [Full Text] [Related]  

  • 2. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
    Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
    Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different p53 mutation patterns in colorectal tumors from smokers and nonsmokers.
    Huang CC; Cheng YW; Chen MC; Lin YS; Chou MC; Lee H
    Environ Mol Mutagen; 2006 Aug; 47(7):527-32. PubMed ID: 16721749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas.
    Smith DR; Ji CY; Goh HS
    Br J Cancer; 1996 Jul; 74(2):216-23. PubMed ID: 8688324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.
    de Jong KP; Gouw AS; Peeters PM; Bulthuis M; Menkema L; Porte RJ; Slooff MJ; van Goor H; van den Berg A
    Clin Cancer Res; 2005 Jun; 11(11):4067-73. PubMed ID: 15930341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines.
    Liu Y; Bodmer WF
    Proc Natl Acad Sci U S A; 2006 Jan; 103(4):976-81. PubMed ID: 16418264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression of mutation p53 gene from circulating cancer cells of peripheral blood and the clinical significance in detecting the patients with colorectal cancer].
    Ma GJ; Zhou JN; Shen ZL; Chen SQ; Zhu YQ; Wu XL; Xue KX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):186-8. PubMed ID: 16604493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas.
    Dix B; Robbins P; Carrello S; House A; Iacopetta B
    Br J Cancer; 1994 Oct; 70(4):585-90. PubMed ID: 7917901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of p53 codon 72 polymorphism with liver metastases of colorectal cancers positive for p53 overexpression.
    Zhu ZZ; Liu B; Wang AZ; Jia HR; Jin XX; He XL; Hou LF; Zhu GS
    J Zhejiang Univ Sci B; 2008 Nov; 9(11):847-52. PubMed ID: 18988302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient with multiple primary carcinomas including 4 separate oral cancers: study of p53 mutations and their implications for management.
    Fukuda M; Nakatsuka T; Kusama K; Sakashita H
    J Oral Maxillofac Surg; 2006 Nov; 64(11):1672-9. PubMed ID: 17052595
    [No Abstract]   [Full Text] [Related]  

  • 13. [Analysis of p53 protein in clinical research].
    Remvikos Y
    Pathol Biol (Paris); 1993 Jan; 41(1):19-20. PubMed ID: 8316452
    [No Abstract]   [Full Text] [Related]  

  • 14. Colorectal cancer prognosis: is it all mutation, mutation, mutation?
    Hassan AB; Paraskeva C
    Gut; 2005 Sep; 54(9):1209-11. PubMed ID: 16099785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for routine p53 testing in colorectal cancer?
    Hoff PM
    J Clin Oncol; 2005 Oct; 23(30):7395-6. PubMed ID: 16186590
    [No Abstract]   [Full Text] [Related]  

  • 17. p53 protein accumulation and p53 gene mutation in colorectal cancer.
    Nasierowska-Guttmejer A; Trzeciak L; Nowacki MP; Ostrowski J
    Pathol Oncol Res; 2000; 6(4):275-9. PubMed ID: 11173660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of the expression of p53 gene in colorectal carcinoma by using real-time PCR.
    Bong I; Lim P; Balraj P; Sim Ui Hang E; Zakaria Z
    Trop Biomed; 2006 Jun; 23(1):53-9. PubMed ID: 17041552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis.
    Kukitsu T; Takayama T; Miyanishi K; Nobuoka A; Katsuki S; Sato Y; Takimoto R; Matsunaga T; Kato J; Sonoda T; Sakamaki S; Niitsu Y
    Clin Cancer Res; 2008 Jan; 14(1):48-54. PubMed ID: 18172251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [TP53 mutations and molecular epidemiology].
    Otsuka K; Ishioka C
    Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.